1-3 of 3
Leda Leoncini
Close
Sort by
Journal Articles

5-Azacytidine to Treat Acute Myeloid Leukemia In Elderly or Frail Patients: A Phase II Study (SAKK 30/07)

Jakob R. Passweg, MD, MS, Thomas Pabst, Sabine Blum, Mario Bargetzi, Hong Sun, Dominik Heim, MD, Georg Stussi, MD, Michael Gregor, Leda Leoncini, Sandrine Meyer-Monard, MD, Peter Brauchli, Yves Chalandon, MD
Journal: Blood
Blood (2010) 116 (21): 2181.
https://doi.org/10.1182/blood.V116.21.2181.2181
Published: 2010
Journal Articles

A Randomized Study of Daily Versus Weekly Administration of 2-Chlorodeoxyadenosine in Patients with Hairy Cell Leukemia.

Reinhard Zenhausern, MD, Nicolas Leupin, Shu-Fang Hsu Schmitz, Max Solenthaler, Andre Tichelli, Dominik Heim, Urs Hess, Leda Leoncini, Mario Bargetzi, Andreas Tobler
Journal: Blood
Blood (2007) 110 (11): 1352.
https://doi.org/10.1182/blood.V110.11.1352.1352
Published: 2007
Journal Articles

Factors Prognostic for Response and Event Free Survival and Treatment Related Toxicity in 306 Patients with Follicular or Mantle Cell Lymphoma Randomized to Single Agent Rituximab Given at the Standard or at a Prolonged Schedule.

Michele Ghielmini, Kaspar Rufibach, Gilles Salles, Sergio Cogliatti, Leda Leoncini-Franscini, Claire Leger-Falandry, Martin Fey, Thomas Cerny, Giovanni Martinelli, Rolf Stahel, Andreas Lohri, Nicolas Ketterer, Martin Wernli
Journal: Blood
Blood (2004) 104 (11): 588.
https://doi.org/10.1182/blood.V104.11.588.588
Published: 2004